OCUL

OCULAR THERAPEUTIX, INC

NasdaqAdd to watchlist

Healthcare · Biotechnology

$10.36

−$0.46−4.25%

Delayed · 2026-08-28T20:00:00.000Z · marketstack

Aug 10, 2026$10.36

+$1.12+12.12%over 1M

Day range5% of range

$10.33$10.97

Session

Previous close: $10.82
Open: $10.97
Volume: 1.56M
Avg volume: -
Day high: $10.97
Day low: $10.33

Fundamentals

Visualize fundamentals and more

Market cap: 2.33B
P/E ratio: -
EPS (TTM): -$1.34
Dividend yield: -
Beta: 0.97
Shares outstanding: 224.95M

Source SEC EDGAR · 9/10/2026

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like OCULAR THERAPEUTIX, INC

Also filed under Biotechnology, ranked by how closely they sit beside OCUL.

MRNAModerna, Inc.
ALNYALNYLAM PHARMACEUTICALS, INC.
REGNREGENERON PHARMACEUTICALS, INC.
VRTXVERTEX PHARMACEUTICALS INC / MA
INSMINSMED Inc
ARGXARGENX SE

Ask about OCULAR THERAPEUTIX, INC

The assistant answers from what OCUL has actually filed: 14 annual reports filed with the SEC and 3 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from OCUL's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding OCULAR THERAPEUTIX, INC, and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with OCULAR THERAPEUTIX, INC

Separate the decisions from the paperwork
Every Form 4 OCUL insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about OCULAR THERAPEUTIX, INC's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.